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Abstract—Pharmaceutical companies today face a growing 
demand for more complex drug designs. In the past few 
decades, a number of probabilistic models have been 
developed, with the aim of improving insight on microscopic 
features of these complex designs. Of particular interest are 
models of controlled release systems, which can provide tools 
to study targeted dose delivery. Controlled release is achieved 
by using polymers with different dissolution characteristics. 
We present here an approach for parallelising a large-scale 
model of a drug delivery system based on Monte Carlo 
methods, as a framework for Cellular Automata mobility. The 
model simulates drug release in the gastro-intestinal tract, 
from coated ethylcellulose microspheres. The objective is high 
performance simulation of coated drugs for targeted delivery. 
The overall aim is to understand the importance of various 
molecular effects with respect to system evolution over time. 
Important underlying mechanisms of the process, such as 
erosion and diffusion, are described. 
Keywords-Drug dissolution, Probabilistic methods, Discrete 
simulation, Computational modelling, Parallelisation 
I.  INTRODUCTION 
Drug delivery systems (DDS) are pharmaceutical 
systems designed for transporting drugs into the body. The 
computational modelling of DDS is a constantly developing 
field, with potential to become an integral part of 
pharmaceutical research. Modern drug formulations can be 
very complex, while influence of system composition and 
variables on the release profiles is not fully understood. 
Modern drug design processes require collaboration between 
pharmacists, bioengineers and computer scientists. In silico 
modelling addresses the main problems of drug development 
through (1) reducing experimental cost, (implicit in large 
amount of in vitro testing), (2) accelerating time for drug 
progression to market, (3) better understanding of drug 
transport processes and (4) converting the existing approach 
from a descriptive to a predictive one. 
Controlled drug delivery systems are a type of DDS, the 
primary objective of which is to deliver drug at the desired 
rate to a targeted site in the body. Control is maintained by 
using polymers of different structures making polymer 
dissolution one of the most important problems to be solved. 
Here, we present an OpenMP based parallelisation model for 
simulation of 3D drug systems. The model is based on a 
combined Monte Carlo (MC) and Cellular Automata (CA) 
approach and simulates controlled release from coated 
microspheres. The main novelties in this work include 
analysis of the effect of the coating structure/material on the 
drug release and the effort to mimic non-homogeneous 
dispersion of the drug, thus improving realism of the model. 
The work is rooted in an ongoing industrial collaboration and 
aims to address the release problem for the drug 
(cyclosporine) in targeting the gastro-intestinal (GI) tract. As 
one of a number of suitable coating materials, we model the 
use of ethylcellulose (EC), a generally non-invasive polymer 
with good film-forming capabilities, ideal for use in matrix 
agents, for prolonged release [Error! Reference source not 
found.]. Due to the thin layer of ethylcellulose used, a very 
fine grained model is required, prompting the need for the 
parallelisation. The reasons for choosing the particular 
parallelization framework are outlined, together with its 
advantages and limitations compared to other industry 
standard parallelisation approaches, when applied to 
simulations of complex pharmaceutical systems. 
II. THEORY 
Theoretical models of DDS vary according to the type 
and complexity of the system, and can be generally divided 
into three broad groups: mechanistic, empirical and 
probabilistic [Error! Reference source not found.]. 
Probabilistic theories have the advantage of applying a 
bottom-up approach, (incorporating stochastic assumptions 
and a simplified representation of the system), but requiring 
less initial information and with the potential to yield better 
predictions compared to other, top-down theories. 
The first step in modelling the dissolution is to determine 
the in vitro dissolution rate under various external 
conditions, as measured in the dissolution test apparatus. 
Standard test methods for measuring these rates are outlined 
in the pharmacopoeias [Error! Reference source not 
found.], [Error! Reference source not found.]. Here, the 
paddle apparatus II, (USP II), was used to mimic metabolic 
conditions, (change of temperature, pH and dynamic flux), 
by varying speed of the paddle, and to monitor, 
experimentally, their influence on the drug dissolution rate. 
Subsequently, model results are evaluated against these 
experimental data. 
A. Drug Dissolution Phenomena 
Important phenomena in polymeric drug delivery systems 
include: (i) Diffusion: represents the motions of molecules 
from a region of higher to one of lower concentration i.e. 
flux. In the modelling of DDS, diffusion is often described 
  
by Fick’s laws, [Error! Reference source not found.]. In 
one dimension, Fick’s first law can be represented as: 
 J = - D δc/δx 
where J is the diffusion flux, D is the diffusion coefficient 
and c is the concentration. (ii) Degradation: the process 
whereby chain scission occurs during which polymer chains 
become oligomers and monomers, facilitating easy release. 
Degradation is the first step of erosion [Error! Reference 
source not found.]. (iii) Erosion: represents the loss of 
material from a polymer due to degradation. It determines 
the release rate of the drug [Error! Reference source not 
found.]. When a polymer erodes it leaves space for the drug 
to be released from the compact, or for water penetration. 
Two types of erosion are defined [Error! Reference source 
not found.]: (a) Surface erosion is a homogeneous process 
and represents the stage during which the size of the 
compact decreases while the shape remains constant; the 
compact looses material only from its surface; (b) Bulk 
erosion is a heterogeneous process with material being lost 
from the whole compact, although the size remains constant.  
III. CURRENT WORK 
This work builds on the basis of a probabilistic model for 
simulation of PLGA microspheres [Error! Reference 
source not found.]. The modelled device here consists of a 
drug, nonhomogenously dispersed in a coated sphere, where 
the coating predominantly controls the rate of drug release. 
The aim of the model is to determine how different 
properties of the device, such as coating thickness or size of 
the sphere, affect the release rates. Monte Carlo and Cellular 
Automata methods are used to describe the system in terms 
of a 3D grid of cells, with erosion and diffusion as the main 
release mechanisms (Figure 1). Microscopic features of the 
model can be investigated through transitions between cell 
states. Each cell can have one of several possible states, 
described (Table 1). The state transitions are influenced by 
the states of all the cells in the Von Neumann neighbourhood 
for a 3D matrix (i.e. 26 neighbouring cells). In its initial 
state, the drug is taken to be randomly dispersed in the form 
of "packets" inside a gelatinous sphere, coated by a polymer 
layer. Diffusion of the drug inside the sphere is represented 
as a random walk of drug packets, influenced by 
concentration differences between neighbouring cells. The 
highest probability for movement will be in the direction of 
the largest concentration gradient, (based on Fick's first law). 
Behaviour of coating layer cells is based on work reported in 
[Error! Reference source not found.], where scission of 
the polymer chains and formation of pores follow the Erlang 
probability distribution. The rate of pore formation is 
characterised by parameter , which defines the lifetime, t, of 
an individual EC cell: 
 
t = 1/λln(U), U  Unif[0, 1]  
 
When the cell lifetime is reached, the cell is considered to 
be fully eroded, and forms a channel through which the drug 
packet can diffuse. This occurs at a rate slower than the 
diffusion rate inside the coating, (solvent cells), reflecting the 
influence of permeability of the membrane [Error! 
Reference source not found.]. The release rate is measured 
by counting the number of packets that reach the buffer zone, 
which is assumed to have perfect sink conditions. 
Figure 1.  Simplified Internal Morphology of one 3D Sphere Simulating 
Drug Dissolution through Coating Layer. Enlarged: Part of the Sphere with 
Definition of Model Cell Types. Bottom: Simulation Stages: Initial (left), 
Release (centre) and Dissolved (right). 
TABLE I.  CELL TYPES AND RULES OF BEHAVIOUR 
Cell type Behaviour description 
Buffer 
Drug is released when it reaches buffer zone. Cell 
type acts as a perfect sink. 
Ethylcellulose 
(EC) 
Drug-free coating layer. Assigned lifetime, based 
on λ (degradation rate) parameter. Forms an EC 
channel cell upon complete erosion. 
EC channel 
Gelatine and drug can diffuse through EC channel 
cells. 
Gelatine 
Fixed lifetime. During diffusion through solvent 
cells, facilitates movement of drug “packets”. 
Solvent 
Gelatine erodes into the solvent. Drug can diffuse 
through the latter. 
Drug packet 
Drug, initially dispersed in gelatine cells. Each cell 
can hold a maximum (saturation) amount of drug 
"packets". 
A. Model Parallelisation 
Using high performance computing facilities, (available 
in-house and at the national centre), we are parallelising the 
model in order to achieve large-scale short simulation times. 
The parallelisation scheme is implemented using GNU 
OpenMP (GOMP). Algorithms are coded using the C++ 
language and OpenGL libraries for graphic representation 
where the latter is useful, in particular, for the development 
and liaison stage. 
 
 
 
 
Initially a sequential, stochastic model for the described 
drug was implemented [Error! Reference source not 
found.], but the dimensional analysis for fine-tuning of 
model precision required a significant number of 
simultaneous runs. However, each run required to produce 
realistic results was time-consuming, so parallelisation was a 
logical step forward in obtaining the speedup, with CA 
models particularly suited to this end, [Error! Reference 
source not found.]. However, special features of the model, 
such as drug packet movement and cell-state transitions 
between the layers, proved non-trivial for this 
implementation. Figure 2 represents the solution for dividing 
3D space into layers suitable for parallelisation. Due to high 
communication demands between the layers, we chose 
OpenMP, an industry standard for shared-memory parallel 
programming [Error! Reference source not found.], that 
has an advantage over other frameworks, (e.g. distributed 
memory, MPI), in that all threads share the same view of the 
overall problem space. While adequate for cellular automata 
communication problems, OpenMP is limited by the 
architecture of the hardware platform used, as it can scale up 
only to the number of processors that share the same 
memory. 
Figure 2.  Parallelisation solution for microsphere geometry for the case of 
4 threads. Each thread shares boundary layer with an adjacent thread 
Observed also, in upgrading the model from sequential to 
parallel implementation, is the fact that the standard C++ 
linear congruential random number generator is unsuitable 
for large scale parallel models as the implementation of the 
generator forces a software lock every time the random 
number generation function is called, causing blocking of 
threads. Due to this, we used a lock-free implementation of 
the Mersenne Twister (MT) random number generator which 
solves the locking problem and also offers a superior period 
length [Error! Reference source not found.]. 
IV. RESULTS 
Based on the available in vitro data, initial model 
parameters were set t: (i) the CA matrix size used was 200 x 
200 x 200, with cell size being 10µm simulating millimetre 
scales of coated microsphere, (ii) maximum lifetimes of 
individual cells for gelatine and ethylcellulose were 60 
minutes and 2 days, respectively, (iii) diameter of the 
microsphere was 1.43 mm, (iv) default weight gain of EC 
coating was 5%, and (v) drug loading was kept constant at 
10.8% of the mass of the sphere. Unless analysed 
specifically, these values were kept constant for all 
simulations. The averaging of the drug release curves for 
these values for 24 repeated runs showed negligible 
variation. The effectiveness of parallelisation to simulation 
speeds was measured by comparing total execution times for 
different number of threads (1, 3, 6 and 12). Results showed 
linear speedup with increase in the thread number. This 
allowed both for simulation on very short time intervals and 
examination of wider ranges of model parameters with the 
potential to yield deeper insight into the causes of observed 
system behaviour. 
Figure 3.  Release Profiles as a Function of the Simulation Time Interval 
The first step in modelling was to determine the most 
appropriate time interval for cell state updates. Since no 
information was available on the diffusion coefficient from 
the literature, to our knowledge, the order of magnitude 
interval was calculated using dimensional analysis based on 
the average release speed obtained from the in vitro data and 
first Fick’s law. To find the best fit interval, we preformed 
simulations for intervals between 0.5 seconds and 70 
seconds, (Figure 3, values higher than 15 sec shown for 
clarity). Comparing results against experimental data, led to 
a choice of time interval = 30 seconds which was used for all 
subsequent simulations. With respect to the physical 
characteristics of the compact, the effect of porosity in the 
coating layer was investigated by varying the lifetime of EC 
cells, (i.e. varying λ parameter), to obtain different release 
behaviours for different lifetimes of polymer chains, (Figure 
5). The slower release rate of the drug observed was due to 
 
 
 
 
 
 
 
 
decreased porosity, i.e. slower chain scission occurring in the 
coating. Weight gain of the coating thickness was also one of 
the primary factors influencing drug formulation and 
performance. Here, we varied the coating levels from 4% - 
8% of the total mass, (Figure 6). The release curves 
reproduced the reduction in diffusion rate, but the impact 
was somewhat smaller than experienced in vitro. This was 
expected, to some extent, as perfect sink conditions were 
modelled here, whereas these do not really occur. In reality, 
the concentration of ethylcellulose in the boundary layer 
inhibits movement of drug packets and some local saturation 
occurs. This phenomenon must be taken into account in 
future model extensions. As can be seen, (Figure 7), the 
lifetime of the gelatine carrier can be considered negligible 
in terms of influence on final release rate. However, gelatine 
is an important controller of the drug release in the initial 
stages, as it influences the "burst effect" by accelerating drug 
transfer through EC channels. 
Figure 4.  Simulated vs experimental results (experimental data provided 
by Sigmoid Pharma Ltd.) 
 
V. FUTURE WORK 
Although simulated results do not reflect quantitative in 
vitro data precisely, (Figure 4), results obtained are 
promising. These show that the model predicts qualitatively 
similar behaviour compared to that seen from experiments. 
Results also show that the behaviour of EC cannot be 
modelled using erosion only, but that other phenomena, such 
as swelling, which influences volume increase, due to 
increased hydration of the broken polymer chains, have to be 
taken into account [Error! Reference source not found.]. 
Thus, the future focus for the model will be incorporation of 
the swelling effect, caused by additives to the coating 
structure. Additionally, the model will be augmented to 
include the effect of different media surrounding the drug, 
(biphasic release), in order to simulate different stages of the 
GI tract environment. Nevertheless, the approach to date 
facilitates comparison of simulated and experimental release 
curves, allowing us to determine key parameters and their 
values for this novel formulation, and to reproduce 
qualitative behaviour and best fit. With the introduction of 
parallelisation, the model became significantly more scalable 
allowing fast simulation times at fine-grained resolutions. 
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Figure 5.  Release Profiles as a Function of the Coating Degradation Rate 
Lambda. Legend represents inverse lambda values. In brackets: equivalent 
amount of eroded EC in 24h 
Figure 6.  Release Profiles as a Function of Coating Weight Gain. 
Figure 7.  Release profiles as a Function of Gelatine Lifetime. 
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